Insider buying last 90 days
No open-market insider purchases were filed for CRON in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every CRON insider filing, plotted on the chart in Gekko.Open CRON in Gekko
NASDAQ: CRON
Cronos Group Inc. Common (CRON) Stock Analysis & Forecast
Oct 12 close
$3.21−0.02 (−0.6%)
Gekko Brief
AI summaryOct 12 closeCronos Group moves this week on a mix of strong quarterly results and sector-wide reform speculation. Reports point to Q2 2026 revenue growth and improved margins, with gains attributed to Canadian market share and international expansion into Israel and Germany, alongside a pending acquisition in the Netherlands. Separately, renewed talk of U.S. federal cannabis reclassification has lifted sentiment across the marijuana sector, while coverage also notes an Israeli anti-dumping investigation and intensifying competition in Europe as risks to watch alongside the company's disciplined growth strategy.
CRON closes at $3.21, down 0.6%, sitting between its 50-day average of $3.24 and 200-day average of $2.81. The stock has returned 16.7% over three months and 24.9% over six months. The GekkoIndex reads 59.9, placing it in the Neutral zone, with price currently 9.9% above Gekko Fair Value of $2.92.
Earnings are scheduled for 5 November 2026, before the open, 23 days out and within a typical 20-trading-day holding window; the prior report on 11 May 2026 beat estimates, with EPS of $0.05 against $0.01 expected, and produced a 9.1% reaction. Seasonality over five years shows a 3.3% average 20-day return from this point, rising in 2 of those years. No insider, Congress or unusual options activity appears in the respective 90-day and 30-day windows, though one trailblazer holder is recorded.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Cronos Group Inc. Common price vs fair value
Close $3.21200-day averageGekko Fair Value $2.92
Cronos Group Inc. Common quick facts
- Market cap
- $1.20B
- P/E ratio
- 17.1
- Forward P/E
- 28.7
- EPS, TTM
- $0.19
- Revenue, TTM
- $179.1M
- Profit margin
- 39.1%
- Dividend yield
- —
- Beta
- 1.20
- Volume
- 687,129 avg 867,973
- 1-year return
- +18.5%
- Typical daily move
- ±2.6%
- Typical 20-day move
- ±6.2%
- 50-day average
- $3.24
- 200-day average
- $2.81
- Next earnings
- Nov 5 before open
- Shares outstanding
- 368.4M
Cronos Group Inc. Common swing-trade checklist
Cronos Group Inc. Common scores 0 supportive, 3 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
0 supportive3 mixed2 headwinds
- Trendmixed
Averages disagree
Close $3.21 sits between the 50-day ($3.24) and 200-day ($2.81) averages, or the averages disagree.
See the chart - GekkoIndexmixed
59.9, Neutral
Reading 59.9 is in the Neutral zone.
See the GekkoIndex - Fair valueheadwind
9.9% above
Price is 9.9% above Gekko Fair Value (more than 5% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 24 days
Reports on Nov 5, 2026, 24 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
+3.3% on average
From this point in the calendar, the next 20 trading days averaged +3.3% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Cronos Group Inc. Common stock chart and price history
Cronos Group Inc. Common closed at $3.21 on Oct 12, 2026, +18.5% over the past year, inside a 52-week range of $2.28 to $3.61.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +2.2%
- 3 months
- +16.7%
- 6 months
- +24.9%
- 1 year
- +18.5%
The full CRON chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open CRON in Gekko
Follow Cronos Group Inc. Common through every session
Put CRON on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track CRON in GekkoFree for 7 days. No credit card required.
About Cronos Group Inc. Common
Cronos Group works across the cannabinoid space, building and selling products derived from hemp and cannabis. In the United States, its Lord Jones and Happy Dance lines bring hemp-based wellness and beauty items to shoppers through online stores, retail shelves, and hospitality partnerships, work the company is particularly recognized for.
Beyond hemp, Cronos grows, manufactures, and sells cannabis and cannabis extracts for both medical and recreational use. Its product range spans dried flower, pre-rolls, edibles, concentrates, and extracts, sold wholesale and direct to customers. The wellness side runs under the PEACE NATURALS name, while adult-use goods carry the Spinach brand, and the company also ships dried cannabis and cannabis oils abroad to places including Germany, Israel, and Australia.
Cronos was established in 2012 and is headquartered in Toronto, Canada. Its common shares trade on the NASDAQ under the ticker CRON.
- Listed
- NASDAQ
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Website
- thecronosgroup.com
Cronos Group Inc. Common GekkoIndex: the smart money zone
Cronos Group Inc. Common’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 59.9, in the Neutral zone, up 0.4 points over five sessions.
59.9Neutral
Up 0.4 points over five sessions.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 5 | Too few readings yet | |||
| Accumulation | 221 | +1.6% | +4.4% | ||
| Neutral (current zone) | 419 | +0.1% | +0.8% | ||
| Distribution | 34 | −0.5% | −2.4% | ||
| Selling | 3 | Too few readings yet | |||
Average CRON share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the CRON price, zone by zone.Track CRON in Gekko
Is Cronos Group Inc. Common stock overvalued? Gekko Fair Value
Cronos Group Inc. Common trades 9.9% above Gekko Fair Value of $2.92, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Cronos Group Inc. Common shares are worth, recalculated every trading day.
$2.92
Gekko Fair Value, Oct 9, 2026
9.9% Overvalued
At the end of Aug 2026 the price was 26.2% above the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open CRON in Gekko
Cronos Group Inc. Common insider and Congress trading
No open-market insider purchases were filed for Cronos Group Inc. Common, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in CRON were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for CRON, plotted on the chart in Gekko.Open CRON in Gekko
Buybacks
Cronos Group Inc. Common has been buying back its own shares.
- Latest authorization
- $50.00M, May 11, 2026
- Bought back, quarter ended Jun 30, 2026
- $16.13M
- As a share of market cap
- 1.34%
- Trailing four quarters
- $38.83M
From company filings.
Hedge funds and billionaires quarter ended Dec 31
1of the funds Gekko tracks holds CRON.
0added0opened1trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
Cronos Group Inc. Common earnings: next date and track record
Cronos Group Inc. Common reports on Nov 5, 2026, before the open (24 days away), and beat the EPS estimate in 6 of its last 8 reports.
Next earnings report
Nov 5, 2026
Expected before the open, 24 days away
- EPS estimate
- $0.03
- Revenue estimate
- $49.47M
6 of 8reports beat the EPS estimate
±6.5%average move across the report
6 of 8reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| May 11, 2026 | $0.05 est $0.01 | $45.21M est $42.20M | +9.1% |
| Feb 26, 2026 | $0.00 est $0.02 | $44.53M est $38.72M | −3.6% |
| Nov 6, 2025 | $0.10 est $0.02 | $36.34M est $38.43M | +1.2% |
| Aug 7, 2025 | −$0.14 est −$0.03 | $32.36M est $37.34M | +9.5% |
| May 8, 2025 | $0.03 est $0.00 | $22.65M est $31.66M | +7.0% |
| Feb 27, 2025 | $0.16 est −$0.01 | $21.06M est $33.68M | +10.8% |
| Nov 12, 2024 | $0.03 est −$0.01 | $25.25M est $34.54M | +10.2% |
| Aug 8, 2024 | −$0.02 est −$0.07 | $20.30M est $19.02M | −0.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Cronos Group Inc. Common stock forecast and analyst price targets
Analysts’ average 12-month price target for Cronos Group Inc. Common is $2.46, −23.3% from the last close.
$2.46consensus 12-month target, −23.3% from the last close
+0.8%average 20-day move after past Neutral readings
+3.3%average move over the next 20 trading days in the last 5 years
±2.6%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Cronos Group Inc. Common seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, Cronos Group Inc. Common averaged +3.3% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.4% | 2 of 5 |
| Next 10 trading days | +1.8% | 4 of 5 |
| Next 15 trading days | +2.3% | 2 of 5 |
| Next 20 trading days | +3.3% | 2 of 5 |
| Next 30 trading days | −1.8% | 2 of 5 |
For scale, CRON’s typical 20-trading-day move in either direction is about 6.2%.
Cronos Group Inc. Common market cap and key statistics
Cronos Group Inc. Common’s market cap is $1.20B, with a P/E ratio of 17.1 and revenue of $179.1M over the last twelve months.
Valuation
- Market cap
- $1.20B
- P/E ratio
- 17.1
- Forward P/E
- 28.7
- EPS, TTM
- $0.19
- Gekko Fair Value
- $2.92
Trading
- Volume
- 687,129
- Avg volume, 20 days
- 867,973
- 52-week high
- $3.61
- 52-week low
- $2.28
- Shares outstanding
- 368.4M
Financials
- Revenue, TTM
- $179.1M
- Profit margin
- 39.1%
- Return on equity
- 7%
- Quarterly earnings growth, YoY
- +126.8%
Risk and income
- Beta
- 1.20
- Typical daily move
- ±2.6%
- Typical 20-day move
- ±6.2%
Cronos Group Inc. Common stock news this week
Coverage of Cronos Group Inc. Common this week reads positive: 9 positive, 9 neutral and 0 negative headlines.
- Is Cronos Group (TSX:CRON) Making Progress in Cannabis Operations?Kalkine Media, Oct 12
- When Is the Cronos Group Inc. (TSX:CRON) Q3 Earnings Call Scheduled?Kalkine Media, Oct 12
- Can Cronos Group (NASDAQ:CRON) Extend Its Global Footprint As Reform Talk Resurfaces?Kalkine Media, Oct 12
- Is Strong Revenue Growth Behind Cronos Group's (NASDAQ:CRON) Surge?Kalkine Media, Oct 12
- Cronos Group (TSX:CRON) Earnings Beat Puts Valuation Back In FocusSimply Wall Street, Oct 11
- CRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out?TradingView, Oct 9
Cronos Group Inc. Common peers
Cronos Group Inc. Common’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| RVMDRevolution Medicines | Accumulation | 6.4% below |
| BHCBausch Health Companies | Neutral | 39.1% below |
| BRBRBellRing Brands | Accumulation | 45.8% below |
| AVBPArriVent BioPharma | Buying | 38.7% below |
| USNAUSANA Health Sciences | Neutral | 42.9% below |
| NATRNature's Sunshine Products | Accumulation | 43.9% below |
A peer links to its own page where one exists.
Cronos Group Inc. Common stock FAQ
What is Cronos Group Inc. Common’s market cap?
Cronos Group Inc. Common’s market cap is $1.20B at the Oct 12, 2026 close of $3.21, with 368.4M shares outstanding. The shares trade on a P/E ratio of 17.1.
What is the Cronos Group Inc. Common stock forecast?
The consensus analyst 12-month price target for Cronos Group Inc. Common is $2.46, −23.3% from the last close. Gekko doesn’t publish price predictions of its own.
Is Cronos Group Inc. Common stock overvalued or undervalued?
On Gekko’s estimate Cronos Group Inc. Common is overvalued: the Oct 12, 2026 close of $3.21 is 9.9% above Gekko Fair Value of $2.92. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Cronos Group Inc. Common report earnings next?
Cronos Group Inc. Common is expected to report on Nov 5, 2026, before the market opens (24 days away). Analysts expect earnings of $0.03 per share on revenue of $49.47M. Cronos Group Inc. Common beat the earnings estimate in 6 of its last 8 reports, moving 6.5% on average across the report.
What is Cronos Group Inc. Common’s 52-week high and low?
Cronos Group Inc. Common’s 52-week high is $3.61 and its 52-week low is $2.28; it closed at $3.21 on Oct 12, 2026, +18.5% over the past year. Over the last five years the shares peaked at $6.79 on Nov 8, 2021.
Is Cronos Group Inc. Common stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 0 of the 5 items with data read as supportive, 3 as mixed (trend, gekkoindex and seasonality) and 2 as headwinds (fair value and earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Cronos Group Inc. Common the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.